Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Savarirayan, R; Tofts, L; Irving, M; Wilcox, WR; Bacino, CA; Hoover-Fong, J; Font, RU; Harmatz, P; Rutsch, F; Bober, MB; Polgreen, LE; Ginebreda, I; Mohnike, K; Charrow, J; Hoernschemeyer, D; Ozono, K; Alanay, Y; Arundel, P; Kotani, Y; Yasui, N; White, KK; Saal, HM; Leiva-Gea, A; Luna-Gonzalez, F; Mochizuki, H; Basel, D; Porco, DM; Jayaram, K; Fisheleva, E; Huntsman-Labed, A; Day, JRS – 2021